Results 171 to 180 of about 9,933,382 (352)
Bone metastasis in prostate cancer (PCa) patients is a clinical hurdle due to the poor understanding of the supportive bone microenvironment. Here, we identify stearoyl‐CoA desaturase (SCD) as a tumor‐promoting enzyme and potential therapeutic target in bone metastatic PCa.
Alexis Wilson +7 more
wiley +1 more source
Glenn Gould’s “Constant Rhythmic Reference Point”: Communicating Pulse in Bach’s Goldberg Variations, 1955 and 1981 [PDF]
Peter Martens
openalex +1 more source
We reconstituted Synechocystis glycogen synthesis in vitro from purified enzymes and showed that two GlgA isoenzymes produce glycogen with different architectures: GlgA1 yields denser, highly branched glycogen, whereas GlgA2 synthesizes longer, less‐branched chains.
Kenric Lee +3 more
wiley +1 more source
A multi-objective particle swarm algorithm based on hierarchical clustering reference point maintenance. [PDF]
Chen S, Liu Y, Yang J, Ouyang A, Yu J.
europepmc +1 more source
AZD9291 has shown promise in targeted cancer therapy but is limited by resistance. In this study, we employed metabolic labeling and LC–MS/MS to profile time‐resolved nascent protein perturbations, allowing dynamic tracking of drug‐responsive proteins. We demonstrated that increased NNMT expression is associated with drug resistance, highlighting NNMT ...
Zhanwu Hou +5 more
wiley +1 more source
HPV Vaccine Uptake and Cervical Cancer Trends in Panama: A Reference Point for Future Impact Studies. [PDF]
Calvo A +6 more
europepmc +1 more source
Reference Point Methods in Vector Optimization and Decision Support [PDF]
Andrzej P. Wierzbicki
openalex
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham +21 more
wiley +1 more source

